Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan

被引：0
作者：
Benjamin Chastek
Kathleen M. Fox
Crystal Watson
Shravanthi R. Gandra
机构：
[1] OptumInsight,
[2] Strategic Healthcare Solutions,undefined
[3] LLC,undefined
[4] Amgen Inc.,undefined
来源：
Advances in Therapy | 2012年 / 29卷
关键词：
Adalimumab; Etanercept; Discontinuation; Persistence; Psoriatic arthritis; Switch; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [41] Low Doses of Etanercept Can Be Effective to Maintain Remission in Psoriatic Arthritis Patients
    de Stefano, Renato
    Frati, Elena
    de Quattro, Davide
    de Stefano, Ludovico
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (03) : 127 - 131
  • [42] Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
    Puig, Lluis
    Rodriguez Fernandez-Freire, Lourdes
    Burgos-Pol, Ramon
    Gomez, Ismael
    Peral, Carmen
    Gomez, Susana
    Rebollo Laserna, Francisco Jose
    DERMATOLOGY AND THERAPY, 2019, 9 (03) : 479 - 496
  • [43] Treatment Patterns Following Discontinuation of Adalimumab, Etanercept, and Infliximab in a US Managed Care Sample
    Yeaw, Jason
    Watson, Crystal
    Fox, Kathleen M.
    Schabert, Vernon F.
    Goodman, Seth
    Gandra, Shravanthi R.
    ADVANCES IN THERAPY, 2014, 31 (04) : 410 - 425
  • [44] Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis
    Mease, PJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1491 - 1504
  • [45] Treatment Patterns Following Discontinuation of Adalimumab, Etanercept, and Infliximab in a US Managed Care Sample
    Jason Yeaw
    Crystal Watson
    Kathleen M. Fox
    Vernon F. Schabert
    Seth Goodman
    Shravanthi R. Gandra
    Advances in Therapy, 2014, 31 : 410 - 425
  • [46] Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practice
    Laas, K.
    Peltomaa, R.
    Puolakka, K.
    Kautiainen, H.
    Leirisalo-Repo, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 315 - 320
  • [47] Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)
    Kameda, Hideto
    Ishii, Kentaro
    Kiriyama, Junna
    Mikami, Toshiaki
    Uratsuji, Hideya
    Morita, Akimichi
    RHEUMATOLOGY AND THERAPY, 2025, : 493 - 511
  • [48] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    María M. Katsicas
    Ricardo A. G. Russo
    Clinical Rheumatology, 2009, 28 : 985 - 988
  • [49] Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System
    Ribeiro dos Santos, Jessica Barreto
    Almeida, Alessandra Maciel
    Acurcio, Francisco de Assis
    de Oliveira Junior, Haliton Alves
    Kakehasi, Adriana Maria
    Guerra Junior, Augusto Afonso
    Bennie, Marion
    Godman, Brian
    Alvares, Juliana
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (06) : 539 - 549
  • [50] The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis-preliminary report
    Krawczyk, Agata
    Strzalka-Mrozik, Barbara
    Wcislo-Dziadecka, Dominika
    Kimsa-Dudek, Magdalena
    Kruszniewska-Rajs, Celina
    Gola, Joanna
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (04) : 1080 - 1091
12345